Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
The Latest Breaking News from Leukemia
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Get all your
news in one place.
news in one place.
100’s of premium titles.
One news app.
One news app.
Get all your
news in one place.
news in one place.
100’s of premium titles.
One news app.
One news app.
People
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Organisations
NYSE
17,911 stories
Nasdaq
17,126 stories
Texans
6,748 stories
FDA
4,112 stories
Alabama
3,021 stories
Houston Texans
2,968 stories
NHL
2,627 stories
Pfizer
1,681 stories
Belfast Live
1,640 stories
Moderna
866 stories
Cancer Research UK
556 stories
Eli Lilly
523 stories
Ducks
432 stories
BLUE
345 stories
SWNSZenger
272 stories
Novartis
113 stories
Gilead
94 stories
BMO Capital
82 stories
European Medicines Agency
77 stories
Gilead Sciences
67 stories
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Topics
Covid-19
27,804 stories
Cancer
15,193 stories
Gold
10,753 stories
Disease
9,359 stories
Anxiety
1,868 stories
Breast Cancer
1,533 stories
STEM
1,233 stories
Obesity
926 stories
Chemotherapy
739 stories
Clinical Trial
308 stories
melanoma
257 stories
Oncology
166 stories
Gene Therapy
117 stories
Prescription Drug
107 stories
Leukemia
104 stories
Sickle Cell Disease
70 stories
Ulcerative Colitis
49 stories
Places
United States
189,951 stories
United Kingdom
88,576 stories
China
32,575 stories
France
19,267 stories
Glasgow
16,031 stories
Paris
12,721 stories
Nottingham
7,939 stories
NI
2,502 stories
Singapore
2,270 stories
Buffalo
1,167 stories
Hertfordshire
152 stories
Ballymena
104 stories
Syracuse
68 stories